Constrained Optimization for the Selection of Influenza Vaccines to Maximize the Population Benefit: A Demonstration Project
Open Access
- 22 November 2019
- journal article
- research article
- Published by Springer Nature in Applied Health Economics and Health Policy
- Vol. 18 (4) , 519-531
Abstract
Background Influenza is an infectious disease causing a high annual economic and public health burden. The most efficient management of the disease is through prevention with vaccination. Many influenza vaccines are available, with varying efficacy and cost, targeting different age groups. Therefore, strategic decision-making about which vaccine to deliver to whom is warranted to improve efficiency. Objective We present the use of a constrained optimization (CO) model to evaluate targeted strategies for providing influenza vaccines in three adult age groups in the USA. Methods CO was considered for identifying an influenza vaccine provision strategy that maximizes the benefits at constrained annual budgets, by prioritizing vaccines based on return on investment. The approach optimizes a set of predefined outcome measures over several years resulting from an increasing investment using the best combination of influenza vaccines. Results Results indicate the importance of understanding the relative differences in benefits for each vaccine type within and across age groups. Scenario and threshold analyses demonstrate the impact of changing budget distribution over time, price setting per vaccine type, and selection of outcome measure to optimize. Conclusion Significant gains in cost efficiency can be realized for a decision maker using a CO model, especially for a disease like influenza with many vaccine options. Testing the model under different scenarios offers powerful insights into maximum achievable benefit overall and per age group within the predefined constraints of a vaccine budget.Keywords
This publication has 30 references indexed in Scilit:
- Estimating Influenza Disease Burden from Population-Based Surveillance Data in the United StatesPLOS ONE, 2015
- Comparing influenza vaccine efficacy against mismatched and matched strains: a systematic review and meta-analysisBMC Medicine, 2013
- Influenza Illness and Hospitalizations Averted by Influenza Vaccination in the United States, 2005–2011PLOS ONE, 2013
- Epidemic Influenza — Responding to the Expected but UnpredictableNew England Journal of Medicine, 2013
- Selecting a Mix of Prevention Strategies against Cervical Cancer for Maximum Efficiency with an Optimization ProgramPharmacoEconomics, 2012
- Optimisation of breast cancer management in low-resource and middle-resource countries: executive summary of the Breast Health Global Initiative consensus, 2010The Lancet Oncology, 2011
- The need for quadrivalent vaccine against seasonal influenzaVaccine, 2010
- The annual impact of seasonal influenza in the US: Measuring disease burden and costsVaccine, 2007
- Influenza: Emergence and ControlJournal of Virology, 2004
- Optimal Allocation of Resources across Four Interventions for Type 2 DiabetesMedical Decision Making, 2002